Celsion (CLSN) Announces CFDA Approval for Ongoing Phase III OPTIMA Study

Go back to Celsion (CLSN) Announces CFDA Approval for Ongoing Phase III OPTIMA Study
CELSION (NASDAQ: CLSN) Delayed: 1.93 +0.09 (4.89%)
Previous Close $1.84    52 Week High $2.31 
Open $1.84    52 Week Low $0.82 
Day High $1.94    P/E N/A 
Day Low $1.84    EPS $-1.79 
Volume 42,388